Cholesterol & Lipid
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Plaque Burden Is the Main Driver of Risk for Atherosclerotic Events: Beyond Coronary Stenosis
FEATURING
Martin Mortensen
- 255 views
- January 25, 2022
- 2
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 798 views
- August 30, 2024
- 2
University of Texas Southwestern Medical Center
Clinical Case Presentation: Blame the Statin?
FEATURING
Sarah Lieber
- 635 views
- October 14, 2023
- 4
The North American Thrombosis Forum (NATF)
The Critical Importance of Lowering LDL-C in High-Risk Patients
- 420 views
- January 26, 2023
- 3
3rd Annual Montefiore Einstein Preventive Cardiology Conference
Vanquishing Coronary Artery Disease
FEATURING
Caldwell Esselstyn
- 642 views
- November 13, 2019
- 4
Northwestern Medicine: 8th Annual Cardiovascular Update
What's New and Why- Cholesterol Guidelines
FEATURING
Neil Stone
- 423 views
- August 14, 2019
- 3
Cardiometabolic Health Congress (CMHC)
Triglycerides and Cardiovascular Disease
- 433 views
- January 10, 2019
- 3
Nadir Ali
Cholesterol & Lipoprotein Regulation: Are High Cholesterol and LDL Beneficial in Infection/Inflammation Protection?
- 695 views
- December 14, 2020
- 4
University of Colorado Department of Medicine
Improving Outcomes in Peripheral Artery Disease: How Do We Bridge the Gap?
FEATURING
Connie Hess
- 125 views
- February 27, 2024
- 1
Northwestern Medicine: 6th Annual Cardiovascular Update
Dyslipidemia: Who to Treat and When
FEATURING
Neil Stone
- 448 views
- December 11, 2018
- 3
National Lipid Association
Lessons Learned from REDUCE-IT, STRENGTH, PROMINENT; Informing Guidelines
FEATURING
Anandita Kulkarni
- 1,381 views
- October 11, 2023
- 4
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,350 views
- April 3, 2023
- 4
National Lipid Association
What Should the Clinical Lipidologist Do with The REDUCE-IT Results?
FEATURING
Peter Howard Jones
- 775 views
- March 25, 2019
- 4
National Lipid Association
ASCVD Therapy Update: Can Inclisiran Improve Adherence and Change Preventive Cardiology?
FEATURING
Christie Ballantyne
- 785 views
- March 19, 2020
- 4
Cardiology Fiesta 2016
PCSK9 Inhibitors in Clinical Practice
FEATURING
Michael Davidson
- 1,271 views
- December 9, 2016
- 2
Houston Methodist DeBakey Heart and Vascular Center
Guidelines for Managing Cholesterol: Statins and Beyond
FEATURING
Kershaw Patel
- 1,258 views
- July 14, 2022
- 3
Scripps Health
Lp(a) Lowering Therapies: Are Statins, PCSK9i, Lipoprotein Apheresis and RNAi Effective and Safe?
FEATURING
Calvin Yeang
- 805 views
- July 7, 2021
- 4
Naveed Sattar
Can Empagliflozin Successfully Treat T2D Whilst Preventing Heart Failure and Protecting Renal Function?
- 819 views
- November 25, 2020
- 3